Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles

Biomaterials

Volumn 37, Issue , 2015, Pages 425-435

  Ruan, Shaobo ^a   Yuan, Mingqing ^a   Zhang, Li ^a   Hu, Guanlian ^a   Chen, Jiantao ^a   Cun, Xingli ^a   Zhang, Qianyu ^a   Yang, Yuting ^a   He, Qin ^a   Gao, Huile ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Doxorubicin; Glioma; Gold nanoparticles; Sensitive release; Tumor microenvironment

Indexed keywords

FIBER OPTIC SENSORS; GOLD NANOPARTICLES; MAMMALS; METAL NANOPARTICLES; PARTICLE SIZE;

BLOOD-BRAIN BARRIER; DOXORUBICIN; GLIOMA; LOADING CAPACITIES; LOW DENSITY LIPOPROTEIN RECEPTORS; MICROENVIRONMENTS; SENSITIVE RELEASE; TUMOR MICROENVIRONMENT;

TUMORS;

ANGIOPEP 2; DOXORUBICIN; GOLD NANOPARTICLE; HYDRAZONE DERIVATIVE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; UNCLASSIFIED DRUG; ANGIOPEP-2; GOLD; MACROGOL DERIVATIVE; METAL NANOPARTICLE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; GLIOMA; GLIOMA CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; SURVIVAL TIME; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT; ZETA POTENTIAL; ANIMAL; BRAIN NEOPLASMS; CELL FRACTIONATION; CHEMISTRY; DRUG EFFECTS; ENDOSOME; METABOLISM; PATHOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; ULTRASTRUCTURE;

MUS;

ANIMALS; BRAIN NEOPLASMS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; ENDOSOMES; GLIOMA; GOLD; MALE; METAL NANOPARTICLES; MICE; PEPTIDES; POLYETHYLENE GLYCOLS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RATS; SUBCELLULAR FRACTIONS; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT;

EID: 84922324826     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.10.007     Document Type: Article

References (51)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63(1):11-30.
2. Agarwal S., Sane R., Oberoi R., Ohlfest J.R., Elmquist W.F. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev Mol Med 2011, 13:e17.
3. Jain R.K., Shah S.A., Finney P.L. Continuous noninvasive monitoring of pH and temperature in rat Walker 256 carcinoma during normoglycemia and hyperglycemia. JNatl Cancer Inst 1984, 73(2):429-436.
4. Jain R.K., Baxter L.T. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res 1988, 48(24 Pt 1):7022-7032.
5. Torres F.I., Leunig M., Yuan F., Intaglietta M., Jain R.K. Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. Proc Natl Acad Sci U S A 1994, 91(6):2081-2085.
6. Gao H., Pang Z., Jiang X. Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharm Res 2013, 30(10):2485-2498.
7. Yan H., Wang L., Wang J., Weng X., Lei H., Wang X., et al. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano 2012, 6(1):410-420.
8. Ying X., Wen H., Lu W.L., Du J., Guo J., Tian W., et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. JControl Release 2010, 141(2):183-192.
9. Gao H., Qian J., Cao S., Yang Z., Pang Z., Pan S., et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 2012, 33(20):5115-5123.
10. Ito S., Ohtsuki S., Terasaki T. Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier. Neurosci Res 2006, 56(3):246-252.
11. Maletinska L., Blakely E.A., Bjornstad K.A., Deen D.F., Knoff L.J., Forte T.M. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res 2000, 60(8):2300-2303.
12. Jiang X., Xin H., Ren Q., Gu J., Zhu L., Du F., et al. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials 2014, 35(1):518-529.
13. Huang S., Li J., Han L., Liu S., Ma H., Huang R., et al. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. Biomaterials 2011, 32(28):6832-6838.
14. Xin H., Jiang X., Gu J., Sha X., Chen L., Law K., et al. Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 2011, 32(18):4293-4305.
15. Ganta S., Devalapally H., Shahiwala A., Amiji M. Areview of stimuli-responsive nanocarriers for drug and gene delivery. JControl Release 2008, 126(3):187-204.
16. Stuart M.A., Huck W.T., Genzer J., Muller M., Ober C., Stamm M., et al. Emerging applications of stimuli-responsive polymer materials. Nat Mater 2010, 9(2):101-113.
17. Chilkoti A., Dreher M.R., Meyer D.E., Raucher D. Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev 2002, 54(5):613-630.
18. Gao W., Chan J.M., Farokhzad O.C. pH-Responsive nanoparticles for drug delivery. Mol Pharmacol 2010, 7(6):1913-1920.
19. Miyata T., Jige M., Nakaminami T., Uragami T. Tumor marker-responsive behavior of gels prepared by biomolecular imprinting. Proc Natl Acad Sci U S A 2006, 103(5):1190-1193.
20. Schlossbauer A., Kecht J., Bein T. Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica. Angew Chem Int Ed Engl 2009, 48(17):3092-3095.
21. Lee C.C., Cramer A.T., Szoka F.J., Frechet J.M. An intramolecular cyclization reaction is responsible for the invivo inefficacy and apparent pH insensitive hydrolysis kinetics of hydrazone carboxylate derivatives of doxorubicin. Bioconjug Chem 2006, 17(5):1364-1368.
22. Gerweck L.E., Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 1996, 56(6):1194-1198.
23. Jain R.K. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 2001, 46(1-3):149-168.
24. Prabaharan M., Grailer J.J., Pilla S., Steeber D.A., Gong S. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Biomaterials 2009, 30(30):6065-6075.
25. Wang F., Wang Y.C., Dou S., Xiong M.H., Sun T.M., Wang J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 2011, 5(5):3679-3692.
26. Mussi S.V., Sawant R., Perche F., Oliveira M.C., Azevedo R.B., Ferreira L.A., et al. Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced invitro activity and overcomes drug resistance in MCF-7/Adr cells. Pharm Res 2014, 10.1007/s11095-013-1290-2.
27. Liu Y., Fang J., Kim Y.J., Wong M.K., Wang P. Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity. Mol Pharmacol 2014, 11(5):1651-1661.
28. Murphy C.J., Gole A.M., Stone J.W., Sisco P.N., Alkilany A.M., Goldsmith E.C., et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 2008, 41(12):1721-1730.
29. Ghosh P., Han G., De M., Kim C.K., Rotello V.M. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008, 60(11):1307-1315.
30. Lee S.M., Kim H.J., Kim S.Y., Kwon M.K., Kim S., Cho A., et al. Drug-loaded gold plasmonic nanoparticles for treatment of multidrug resistance in cancer. Biomaterials 2014, 35(7):2272-2282.
31. Dreaden E.C., Alkilany A.M., Huang X., Murphy C.J., El-Sayed M.A. The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 2012, 41(7):2740-2779.
32. Perry J.L., Reuter K.G., Kai M.P., Herlihy K.P., Jones S.W., Luft J.C., et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett 2012, 12(10):5304-5310.
33. Ziegler C., Eychmüller A. Seeded growth synthesis of uniform gold nanoparticles with diameters of 15-300nm. JPhys Chem C 2011, 115(11):4502-4506.
34. Yu Z., Schmaltz R.M., Bozeman T.C., Paul R., Rishel M.J., Tsosie K.S., et al. Selective tumor cell targeting by the disaccharide moiety of bleomycin. JAm Chem Soc 2013, 135(8):2883-2886.
35. Gao H., Pan S., Yang Z., Cao S., Chen C., Jiang X., et al. Acascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials 2011, 32(33):8669-8675.
36. Zhang G., Yang Z., Lu W., Zhang R., Huang Q., Tian M., et al. Influence of anchoring ligands and particle size on the colloidal stability and invivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 2009, 30(10):1928-1936.
37. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009, 61(6):428-437.
38. Walkey C.D., Olsen J.B., Guo H., Emili A., Chan W.C. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. JAm Chem Soc 2012, 134(4):2139-2147.
39. Pang Z., Gao H., Yu Y., Guo L., Chen J., Pan S., et al. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin. Bioconjug Chem 2011, 22(6):1171-1180.
40. Bandekar A., Karve S., Chang M.Y., Mu Q., Rotolo J., Sofou S. Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin. Biomaterials 2012, 33(17):4345-4352.
41. Darbha G.K., Ray A., Ray P.C. Gold nanoparticle-based miniaturized nanomaterial surface energy transfer probe for rapid and ultrasensitive detection of mercury in soil, water, and fish. ACS Nano 2007, 1(3):208-214.
42. Lee H., Lee K., Kim I.K., Park T.G. Synthesis, characterization, and invivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials 2008, 29(35):4709-4718.
43. Owens D.R., Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006, 307(1):93-102.
44. Fleige E., Quadir M.A., Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 2012, 64(9):866-884.
45. Mahmoudi M., Lynch I., Ejtehadi M.R., Monopoli M.P., Bombelli F.B., Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 2011, 111(9):5610-5637.
46. Gao H., Yang Z., Zhang S., Cao S., Shen S., Pang Z., et al. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep 2013, 3:2534.
47. Mahmoudi M., Azadmanesh K., Shokrgozar M.A., Journeay W.S., Laurent S. Effect of nanoparticles on the cell life cycle. Chem Rev 2011, 111(5):3407-3432.
48. Gao H., Yang Z., Zhang S., Pang Z., Liu Q., Jiang X. Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. Acta Biomater 2014, 10(2):858-867.
49. Zhan C., Lu W. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery. Curr Pharm Biotechnol 2012, 13(12):2380-2387.
50. Xin H., Sha X., Jiang X., Zhang W., Chen L., Fang X. Anti-glioblastoma efficacy and safety of paclitaxel-loading angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials 2012, 33(32):8167-8176.
51. Shao K., Ding N., Huang S., Ren S., Zhang Y., Kuang Y., et al. Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy. ACS Nano 2014, 8(2):1191-1203.